42 bills in Congress name the 340B program. Two became law. Here is what each one is, how far it has got and where to read it.
119th Congress
Runs to 3 January 2027
About 340B
Other
H.R. 10919Safety Net Provider Drug Pricing Protection Act
Would bar agreements under which certain covered entities, which the bill calls safety net providers, pay more than the ceiling price when they buy a drug and are paid back later by rebate.
Introduced29 October 2026
Latest step
29 October 2026: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Bergman, Jack [R-MI-1], with 13 cosponsors
Where it names 340B: H.R. 10919
… on Energy and Commerce A BILL To amend title III of the Public Health Service Act to ensure that certain safety net providers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. 1. Short title This Act may be cited as the Safety Net Provider Drug Pricing Protection Act . 2. …
Would bar health plans, insurers and pharmacy benefit managers from treating a covered entity or its pharmacy differently because it dispenses 340B drugs, for example by paying less for a 340B drug.
Introduced29 October 2026
Latest step
29 October 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Matsui, Doris O. [D-CA-7], with 15 cosponsors
Where it names 340B: H.R. 10937
… concerned A BILL To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. 1. Short title This Act may be cited as the Preserving Rules Ordered for The Entities Covered Through 340B Act of 2026 or …
Would bar, through 31 December 2028, agreements under which a covered entity pays more than the ceiling price when it buys a drug, and hold back the 340B Rebate Model Pilot Program for the same period.
Introduced9 October 2026
Latest step
9 October 2026: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Bresnahan, Robert P. [R-PA-8], with 34 cosponsors
Where it names 340B: H.R. 10770
… which was referred to the Committee on Energy and Commerce A BILL To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program. 1. Short title This Act may be cited as the 340B Rebate Model Delay Act . 2. Limiting use of rebates under the 340B Program (a) In general Section 340B(a) of …
H.R. 10134Local Health Care Protection Act of 2026
Would let a hospital that was in 340B on 3 July 2025 stay in it, for cost reporting periods ending by 30 September 2030, even if it no longer meets the disproportionate share percentage the program requires. It also orders a study.
Introduced20 August 2026
Latest step
20 August 2026: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Scholten, Hillary J. [D-MI-3]
Where it names 340B: H.R. 10134
… described in subsection (c), but otherwise meets the requirements for being a covered entity under subparagraph (L), (M), or (O) of subsection (a)(4) of section 340B of the Public Health Service Act ( 42 U.S.C. 256b ) and is in compliance with all other requirements of the program under such section, shall be deemed a covered entity …
A broad rewrite of the program. Its sections cover contract pharmacies, a definition of patient, an end to the rebate model pilot, transparency, program integrity, duplicate discounts, a data clearinghouse, financial help for patients, equal treatment by payers, a user fee, and studies.
Introduced5 August 2026
Latest step
5 August 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor
Sen. Moran, Jerry [R-KS], with 5 cosponsors
Where it names 340B: S. 5244
… of contents (a) Short title This Act may be cited as the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act or the SUSTAIN 340B Act . (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. …
A broad rewrite of the program. Its sections cover a definition of patient, contract pharmacies, child sites, what patients pay, data reporting, program integrity, a data clearinghouse, a bar on discrimination by payers, and studies.
Introduced6 July 2026
Latest step
6 July 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Peters, Scott H. [D-CA-50], with 8 cosponsors
Where it names 340B: H.R. 9599
… determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To strengthen the 340B drug discount program. 1. Short title; table of contents (a) Short title This Act may be cited as the Strengthening the Exercise of Controls and Upgrading Requirements …
H.R. 7391Community Health Center Drug Pricing Protection Act
Would bar agreements under which a federally qualified health center pays more than the 340B ceiling price when it buys a drug and is paid back later by rebate.
Introduced5 February 2026
Latest step
5 February 2026: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Bergman, Jack [R-MI-1], with 58 cosponsors
Where it names 340B: H.R. 7391
… Energy and Commerce A BILL To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase. 1. Short title This Act may be cited as the Community Health Center Drug Pricing Protection Act . 2. …
A broad rewrite of the program. Its sections cover contract pharmacies, hospital eligibility and child sites, what patients pay, Medicaid duplicate discounts, reporting by covered entities, a claims data clearinghouse, fees, and equal treatment of covered entities by payers.
Introduced10 September 2025
Latest step
10 September 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Carter, Earl L. "Buddy" [R-GA-1], with 1 cosponsor
Where it names 340B: H.R. 5256
… in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes. 1. Short title; table of contents (a) Short title This Act may be cited as the 340B Affording Care for Communities and …
Would bar a drug maker from putting conditions on a covered entity's purchase of 340B drugs, such as limits on where the drugs are delivered or dispensed or a demand for claims data, and adds a paragraph on contract pharmacies.
Introduced22 July 2025
Latest step
22 July 2025: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Matsui, Doris O. [D-CA-7], with 21 cosponsors
Where it names 340B: H.R. 4581
… bill; which was referred to the Committee on Energy and Commerce A BILL To ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act. 1. Short title This Act may be cited as the 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of …
Would bar a drug maker from putting conditions on a covered entity's purchase of 340B drugs, such as limits on where the drugs are delivered or dispensed or a demand for claims data, and adds a paragraph on contract pharmacies.
Introduced22 July 2025
Latest step
22 July 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor
Sen. Welch, Peter [D-VT], with 2 cosponsors
Where it names 340B: S. 2372
… to the Committee on Health, Education, Labor, and Pensions A BILL To ensure the accessibility of drugs furnished through the drug discount program under section 340B of the Public Health Service Act. 1. Short title This Act may be cited as the 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of …
Would bar a covered entity from using what it earns through 340B to pay for sex reassignment surgeries or hormone treatments for transgender individuals.
Introduced18 March 2025
Latest step
18 March 2025: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Johnson, Dusty [R-SD-At Large], with 10 cosponsors
Where it names 340B: H.R. 2197
… Ezell , Mrs. Bice , Mr. Moore of Alabama , and Mr. Rose ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes. 1. Short title This Act may be cited as the No …
Would add rural emergency hospitals to the providers that can take part in 340B.
Introduced3 January 2025
Latest step
3 January 2025: Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Bergman, Jack [R-MI-1], with 6 cosponsors
Where it names 340B: H.R. 44
… and Commerce A BILL To amend title III of the Public Health Service Act to include rural emergency hospitals in the definition of a covered entity for purposes of the 340B drug discount program. 1. Short title This Act may be cited as the Rural 340B Access Act of 2025 . 2. Including rural emergency hospitals as covered entities for …
Among the things a Medicare Part D pharmacy benefit manager has to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.
Became law3 February 2026
Latest step
3 February 2026: Became Public Law No: 119-75.
Became
Public Law 119-75
Sponsor
Rep. Cole, Tom [R-OK-4]
Introduced
20 January 2026
Where it names 340B: H.R. 7148
… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Earlier versions carried Medicaid pharmacy payment rules for 340B drugs and a pharmacy benefit manager report that named 340B. The text that became law does not name the program.
Became law4 July 2025
Latest step
4 July 2025: Became Public Law No: 119-21.
Became
Public Law 119-21
Sponsor
Rep. Arrington, Jodey C. [R-TX-19]
Introduced
20 May 2025
Where it names 340B: H.R. 1
… the actual acquisition cost (as defined in 447.502 of title 42, Code of Federal Regulations) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …
From an earlier version of the bill. The newest version does not name 340B.
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It also names 340B in its changes to Medicare drug inflation rebates.
Introduced24 September 2026
Latest step
24 September 2026: Read twice and referred to the Committee on Finance.
Sponsor
Sen. Warner, Mark R. [D-VA]
Where it names 340B: S. 5496
… with plan year 2028, units of each dosage form and strength of such part D rebatable drug for which the manufacturer provides a discount under the program under section 340B of the Public Health Service Act. ; and (ii) in paragraph (6), by striking information and all that follows through rebatable covered part D drug dispensed and …
Would set up a federal program to buy hepatitis C treatments, and bar providers and pharmacies from using 340B for treatments obtained through it.
Introduced14 July 2026
Latest step
14 July 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Miller-Meeks, Mariannette [R-IA-1], with 6 cosponsors
Where it names 340B: H.R. 9682
… Health care providers, pharmacies, and sites of dispensing shall not utilize any other Federal drug discount program, including the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), with respect to hepatitis C treatments obtained through the program. (ii) Enforcement To ensure compliance with …
Would have high-revenue tax-exempt hospital organizations that are covered entities report 340B figures on their tax return: the people given 340B drugs by type of insurance, what was paid for those drugs above the ceiling price, and what it cost to take part.
Introduced29 June 2026
Latest step
1 July 2026: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 25 - 15.
Sponsor
Rep. Murphy, Gregory F. [R-NC-3], with 1 cosponsor
Where it names 340B: H.R. 9504
… advertising information, (B) the specified health service line information, and (C) in the case of an organization which is a covered entity described in section 340B(a)(4) of the Public Health Service Act, the specified Federal 340B drug discount program information. (2) Specified advertising information For purposes of this …
Two sections would add reporting for hospitals in 340B: yearly data on how they provide care for patients, to be published by the Department of Health and Human Services, and reports by disproportionate share hospitals on their low-income utilization rate.
Introduced14 May 2026
Latest step
14 May 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Workforce, the Judiciary, Oversight and Government Reform, Rules, the Budget, Armed Services, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Westerman, Bruce [R-AR-4]
Where it names 340B: H.R. 8840
… information. Sec. 323. Advisory group on reducing burden of hospital administrative requirements. Sec. 324. Data reporting to improve the transparency regarding how 340 B hospital covered entities provide care for patients. Sec. 325. Requiring 340 B drug discount program reports by DSH hospital covered entities on low-income utilization …
H.R. 6575CommonGround for Affordable Health Care Act
Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.
Introduced10 December 2025
Latest step
10 December 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Kiggans, Jennifer A. [R-VA-2], with 38 cosponsors
Where it names 340B: H.R. 6575
… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …
H.R. 6501Bipartisan Health Insurance Affordability Act
Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.
Introduced9 December 2025
Latest step
9 December 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Fitzpatrick, Brian K. [R-PA-1], with 22 cosponsors
Where it names 340B: H.R. 6501
… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …
S. 3345PBM Price Transparency and Accountability Act
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.
Introduced4 December 2025
Latest step
4 December 2025: Read twice and referred to the Committee on Finance.
Sponsor
Sen. Crapo, Mike [R-ID], with 27 cosponsors
Where it names 340B: S. 3345
… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.
Introduced10 July 2025
Latest step
10 July 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Carter, Earl L. "Buddy" [R-GA-1], with 71 cosponsors
Where it names 340B: H.R. 4317
… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …
Would set up a federal program to buy hepatitis C treatments, and bar providers and pharmacies from using 340B for treatments obtained through it.
Introduced4 June 2025
Latest step
4 June 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor
Sen. Cassidy, Bill [R-LA], with 1 cosponsor
Where it names 340B: S. 1941
… Health care providers, pharmacies, and sites of dispensing shall not utilize any other Federal drug discount program, including the drug discount program under section 340B of the Public Health Service Act ( 42 U.S.C. 256b ), with respect to hepatitis C treatments obtained through the program. (ii) Enforcement To ensure compliance with …
One section would require a covered entity to give each patient a 340B drug at no more than the price the entity paid for it, and have the Secretary publish what is paid and received for those drugs.
Introduced6 May 2025
Latest step
6 May 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Spartz, Victoria [R-IN-5]
Where it names 340B: H.R. 3222
… health services furnished by the entity are furnished to individuals residing in such a rural area. . 5. Making drugs more affordable for medicare patients Section 340B(a)(5) of the Public Health Service Act ( 42 U.S.C. 256b(a)(5) ) is amended— (1) in subparagraph (C), by striking subparagraphs (A) or (B) and inserting subparagraph …
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity.
Introduced11 March 2025
Latest step
11 March 2025: Read twice and referred to the Committee on Finance.
Sponsor
Sen. Welch, Peter [D-VT], with 3 cosponsors
Where it names 340B: S. 927
… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …
Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs under 340B for which it, or an affiliate, had an arrangement with a covered entity.
Introduced6 March 2025
Latest step
6 March 2025: Read twice and referred to the Committee on Finance.
Sponsor
Sen. Blackburn, Marsha [R-TN], with 7 cosponsors
Where it names 340B: S. 882
… inclusive of the brand name, generic or non-proprietary name, and National Drug Code of covered part D drugs subject to an agreement with a covered entity under section 340B of the Public Health Service Act for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with such a …
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.
Introduced6 March 2025
Latest step
6 March 2025: Read twice and referred to the Committee on Finance.
Sponsor
Sen. Wyden, Ron [D-OR], with 1 cosponsor
Where it names 340B: S. 891
… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …
In its Medicaid pharmacy payment rules, would let a plan or pharmacy benefit manager pay a covered entity more than its cost for a 340B drug, up to what it would pay had the drug been bought outside the program, if the covered entity reports to the Secretary; what is reported would be published by state and by type of covered entity. It would also have Medicare Part D pharmacy benefit managers list the 340B drugs for which they had an arrangement with a covered entity.
Introduced3 March 2025
Latest step
3 March 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Pallone, Frank [D-NJ-6]
Where it names 340B: H.R. 1768
… (as defined in 447.502 of title 42, Code of Federal Regulations, or any successor regulation) for such drug if— (aa) such drug was subject to an agreement under section 340B of the Public Health Service Act; (bb) such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or …
Among the things a Medicare Part D pharmacy benefit manager would have to report is a list of the drugs for which it, or an affiliate, had an arrangement with a 340B covered entity.
Introduced4 February 2025
Latest step
4 February 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsor
Rep. Landsman, Greg [D-OH-1], with 2 cosponsors
Where it names 340B: H.R. 950
… drugs for which the pharmacy benefit manager or an affiliate of the pharmacy benefit manager had a contract or other arrangement with a covered entity under section 340B of the Public Health Service Act in the service area of such plan. (III) Where a drug approved under section 505(c) of the Federal Food, Drug, and Cosmetic Act …